Takuhisa Tamura
Hasuda, 3490196, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
CTG repeat length underlying cardiac events and sudden death in myotonic dystrophy type 1.
Journal: European heart journal open
Published: March 25, 2024
Efficacy of tranilast in preventing exacerbating cardiac function and death from heart failure in muscular dystrophy patients with advanced-stage heart failure: a single-arm, open-label, multicenter study.
Journal: Orphanet journal of rare diseases
Published: January 16, 2024
Tranilast for advanced heart failure in patients with muscular dystrophy: a single-arm, open-label, multicenter study.
Journal: Orphanet journal of rare diseases
Published: November 17, 2021
Study Protocol for a Multicenter, Open-Label, Single-Arm Study of Tranilast for Cardiomyopathy of Muscular Dystrophy.
Journal: The Kurume medical journal
Published: June 17, 2021
Cardiac Conduction Disorders as Markers of Cardiac Events in Myotonic Dystrophy Type 1.
Journal: Journal of the American Heart Association
Published: August 20, 2020
Clinical Care Recommendations for Cardiologists Treating Adults With Myotonic Dystrophy.
Journal: Journal of the American Heart Association
Published: February 19, 2020
A Japanese male with a novel ANO5 mutation with minimal muscle weakness and muscle pain till his late fifties.
Journal: Neuromuscular disorders : NMD
Published: June 16, 2016
Management of atrioventricular conduction abnormalities in myotonic dystrophy
Journal: Rinsho shinkeigaku = Clinical neurology
Published: December 01, 2012
Management of myocardial damage in muscular dystrophy
Journal: Brain and nerve = Shinkei kenkyu no shinpo
Published: November 10, 2011
Showing 1-9 of 9
Last Updated: 09/26/2026